Search Results - "Boyer, Serge"
-
1
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Published in Journal of medicinal chemistry (23-07-2020)“…Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among…”
Get full text
Journal Article -
2
Discovery of a Cyclic Boronic Acid β‑Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
Published in Journal of medicinal chemistry (14-05-2015)“…The increasing dissemination of carbapenemases in Gram-negative bacteria has threatened the clinical usefulness of the β-lactam class of antimicrobials. A…”
Get full text
Journal Article -
3
Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β‑Lactamase Inhibitor QPX7728
Published in Journal of medicinal chemistry (09-12-2021)“…In recognition of the need for effective oral therapies to treat Gram-negative bacterial infections, efforts were directed toward identifying an oral prodrug…”
Get full text
Journal Article -
4
Scalable Synthesis of β‑Lactamase Inhibitor QPX7728 by Sequential Nickel-Catalyzed Boron Insertion into a Benzofuran Substrate and Enantioselective Cyclopropanation of the Resulting Vinylboronate
Published in Organic process research & development (18-03-2022)“…We report the scalable, high-yielding, and highly selective synthesis of the β-lactamase inhibitor QPX7728 featuring two key synthetic steps: nickel-catalyzed…”
Get full text
Journal Article -
5
Development of a Continuous Flow Process for a Matteson Reaction: From Lab Scale to Full-Scale Production of a Pharmaceutical Intermediate
Published in Organic process research & development (17-05-2019)“…Within this paper, we present the design, development, and scale-up of a process for a continuous Matteson reaction to produce a key intermediate toward the…”
Get full text
Journal Article -
6
Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index
Published in Proceedings of the National Academy of Sciences - PNAS (25-09-2007)“…Despite efforts spanning four decades, the therapeutic potential of thyroid hormone receptor (TR) agonists as lipid-lowering and anti-obesity agents remains…”
Get full text
Journal Article -
7
Scalable On-Demand Production of Purified Diazomethane Suitable for Sensitive Catalytic Reactions
Published in Organic process research & development (19-03-2021)“…We have developed a convenient development-scale reactor (0.44 mol/h) to prepare diazomethane from N-methyl-N-nitroso-p-toluenesulfonamide (MNTS) in ∼80%…”
Get full text
Journal Article -
8
Pradefovir: A Prodrug That Targets Adefovir to the Liver for the Treatment of Hepatitis B
Published in Journal of medicinal chemistry (14-02-2008)“…Adefovir dipivoxil, a marketed drug for the treatment of hepatitis B, is dosed at submaximally efficacious doses because of renal toxicity. In an effort to…”
Get full text
Journal Article -
9
Antiviral Efficacy upon Administration of a HepDirect Prodrug of 2′-C-Methylcytidine to Hepatitis C Virus-Infected Chimpanzees
Published in Antimicrobial Agents and Chemotherapy (01-08-2011)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
10
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
Published in ACS medicinal chemistry letters (09-12-2010)“…AMP-activated protein kinase (AMPK) is a heterotrimeric kinase that regulates cellular energy metabolism by affecting energy-consuming pathways such as de novo…”
Get full text
Journal Article -
11
Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs
Published in Journal of medicinal chemistry (27-11-2008)“…Phosphonic acid (PA) thyroid hormone receptor (TR) agonists were synthesized to exploit the poor distribution of PA-based drugs to extrahepatic tissues and…”
Get full text
Journal Article -
12
Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-β-d-arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma
Published in Journal of medicinal chemistry (28-12-2006)“…Cytotoxic nucleosides have proven to be ineffective for the treatment of hepatocellular carcinoma (HCC) due, in part, to their inadequate conversion to their…”
Get full text
Journal Article -
13
Liver-Targeted Prodrugs of 2‘-C-Methyladenosine for Therapy of Hepatitis C Virus Infection
Published in Journal of medicinal chemistry (09-08-2007)“…2‘-C-Methyladenosine exhibits impressive inhibitory activity in the cell-based hepatitis C virus (HCV) subgenomic replicon assay, by virtue of intracellular…”
Get full text
Journal Article -
14
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma
Published in Cancer chemotherapy and pharmacology (01-10-2009)“…Purpose Hepatocellular carcinoma (HCC) is a life-threatening condition with only one drug treatment regimen approved for use. Oncolytic nucleosides are…”
Get full text
Journal Article -
15
Adenosine Kinase Inhibitors. 5. Synthesis, Enzyme Inhibition, and Analgesic Activity of Diaryl-erythro-furanosyltubercidin Analogues
Published in Journal of medicinal chemistry (06-10-2005)“…Adenosine is an endogenous neuromodulator that when produced in the central and the peripheral nervous systems has anticonvulsant, anti-inflammatory, and…”
Get full text
Journal Article -
16
Design, Synthesis, and Characterization of a Series of Cytochrome P450 3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver
Published in Journal of the American Chemical Society (28-04-2004)“…A new class of phosphate and phosphonate prodrugs, called HepDirect prodrugs, is described that combines properties of rapid liver cleavage with high plasma…”
Get full text
Journal Article -
17
Stereoselective synthesis of 4- C-methyl-2,3,5-tri- O-benzyl- d-ribofuranose and 4- C-methyl-2,3,5-tri- O-benzyl- l-lyxofuranose
Published in Tetrahedron letters (19-05-2003)“…Sugar intermediates 4- C-methyl-2,3,5-tri- O-benzyl- d-ribofuranose ( 8b ) and 4- C-methyl-2,3,5-tri- O-benzyl- l-lyxofuranose ( 8a ) were synthesized by…”
Get full text
Journal Article -
18
Specific Inhibition of Formation of Transcription Complexes by a Calicheamicin Oligosaccharide: A Paradigm for the Development of Transcriptional Antagonists
Published in Proceedings of the National Academy of Sciences - PNAS (27-09-1994)“…Sequence-specific DNA ligands that antagonize DNA-protein interactions represent a potentially powerful means of modulating gene expression. Calicheamicin γ1…”
Get full text
Journal Article -
19
Studies Related to the Carbohydrate Sectors of Esperamicin and Calicheamicin: Definition of the Stability Limits of the Esperamicin Domain and Fashioning of a Glycosyl Donor from the Calicheamicin Domain
Published in Journal of the American Chemical Society (01-05-1995)Get full text
Journal Article -
20
Interaction of calicheamicin γ1I and its related carbohydrates with DNA–protein complexes
Published in Proceedings of the National Academy of Sciences - PNAS (14-09-1999)“…We report studies of the contribution of DNA structure, holding the sequence constant, to the affinity of calicheamicin γ 1 I and its aryltetrasaccharide…”
Get full text
Journal Article